(Q44179968)

30 November 2017

title

Lipoprotein abnormalities in hemodialysis and continuous ambulatory peritoneal dialysis patients (English)

1 reference

30 November 2017

0 references

1 reference

Christina I Fytili

1

1 reference

30 November 2017

Euaggelia G Progia

2

1 reference

30 November 2017

Stelios A Panagoutsos

3

1 reference

30 November 2017

Elias D Thodis

4

1 reference

30 November 2017

Ploumis S Passadakis

5

1 reference

30 November 2017

Kostas I Sombolos

6

1 reference

30 November 2017

Vassilis A Vargemezis

7

1 reference

30 November 2017

publication date

1 September 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

24

1 reference

30 November 2017

issue

5

1 reference

30 November 2017

page(s)

623-630

1 reference

Lp(a) lipoprotein in cardiovascular disease

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120013966

Effect of Lp(a) on the early functional and structural changes of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120013966

Serum apolipoprotein profile of patients with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120013966

Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120013966

Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120013966

Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120013966

Modulation of lipoprotein(a) atherogenicity by high density lipoprotein cholesterol levels in middle-aged men with symptomatic coronary artery disease and normal to moderately elevated serum cholesterol. Regression Growth Evaluation Statin Study (RE

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120013966

Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120013966

Lipoprotein(a) as a risk factor for coronary artery disease in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120013966

Lipoprotein(a) is a predictor for cardiovascular mortality of hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120013966

Apolipoprotein AI and apolipoprotein B containing particle analysis in normolipidemic hemodialyzed patients: evidence of free apolipoprotein E

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120013966

21 January 2018

Identifiers

DOI

10.1081/JDI-120013966

1 reference

30 November 2017

1 reference